InvestorsHub Logo
icon url

pijoe

08/04/19 5:41 PM

#24080 RE: Mogles #24079

Obviously it's a point that needs to be in the thought process. I would look more at the immunotherapies that have been approved as well as their toxicity issues and effectiveness compared to the same when talking about Multikine....... Pretty sure Multikine wont need another safety study.....


Have you even researched her Cempra????